Skogs Marie, Stadler Charlotte, Schutten Rutger, Hjelmare Martin, Gnann Christian, Björk Lars, Poser Ina, Hyman Anthony, Uhlén Mathias, Lundberg Emma
Science for Life Laboratory, Royal Institute of Technology , SE-114 28 Stockholm, Sweden.
Molecular Cell Biology and Genetics, Max Planck Institute , D- 01307 Dresden, Germany.
J Proteome Res. 2017 Jan 6;16(1):147-155. doi: 10.1021/acs.jproteome.6b00821. Epub 2016 Oct 26.
Antibodies are indispensible research tools, yet the scientific community has not adopted standardized procedures to validate their specificity. Here we present a strategy to systematically validate antibodies for immunofluorescence (IF) applications using gene tagging. We have assessed the on- and off-target binding capabilities of 197 antibodies using 108 cell lines expressing EGFP-tagged target proteins at endogenous levels. Furthermore, we assessed batch-to-batch effects for 35 target proteins, showing that both the on- and off-target binding patterns vary significantly between antibody batches and that the proposed strategy serves as a reliable procedure for ensuring reproducibility upon production of new antibody batches. In summary, we present a systematic scheme for antibody validation in IF applications using endogenous expression of tagged proteins. This is an important step toward a reproducible approach for context- and application-specific antibody validation and improved reliability of antibody-based experiments and research data.
抗体是不可或缺的研究工具,但科学界尚未采用标准化程序来验证其特异性。在此,我们提出一种策略,通过基因标签系统地验证用于免疫荧光(IF)应用的抗体。我们使用108种在内源水平表达EGFP标记靶蛋白的细胞系,评估了197种抗体的靶向和非靶向结合能力。此外,我们评估了35种靶蛋白的批次间效应,结果表明抗体批次之间的靶向和非靶向结合模式均存在显著差异,并且所提出的策略是确保生产新抗体批次时可重复性的可靠程序。总之,我们提出了一种使用标记蛋白的内源性表达在IF应用中进行抗体验证的系统方案。这是朝着针对特定背景和应用的抗体验证的可重复方法以及提高基于抗体的实验和研究数据的可靠性迈出的重要一步。